BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tarazi EM, Harter JG, Zimmerman HJ, Ishak KG, Eaton RA. Sulindac-associated hepatic injury: Analysis of 91 cases reported to the food and drug administration. Gastroenterology 1993;104:569-74. [DOI: 10.1016/0016-5085(93)90428-f] [Cited by in Crossref: 68] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
Number Citing Articles
1 Kaplowitz N. Drug-induced liver disorders: implications for drug development and regulation. Drug Saf. 2001;24:483-490. [PMID: 11444721 DOI: 10.2165/00002018-200124070-00001] [Cited by in Crossref: 178] [Cited by in F6Publishing: 150] [Article Influence: 8.9] [Reference Citation Analysis]
2 Zou W, Roth RA, Younis HS, Burgoon LD, Ganey PE. Oxidative stress is important in the pathogenesis of liver injury induced by sulindac and lipopolysaccharide cotreatment. Toxicology 2010;272:32-8. [PMID: 20371263 DOI: 10.1016/j.tox.2010.03.015] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
3 Davies NM, Watson MS. Clinical pharmacokinetics of sulindac. A dynamic old drug. Clin Pharmacokinet 1997;32:437-59. [PMID: 9195115 DOI: 10.2165/00003088-199732060-00002] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 2.1] [Reference Citation Analysis]
4 Tiwari S, Yang J, Morisseau C, Durbin-Johnson B, Hammock BD, Gomes AV. Ibuprofen alters epoxide hydrolase activity and epoxy-oxylipin metabolites associated with different metabolic pathways in murine livers. Sci Rep 2021;11:7042. [PMID: 33782432 DOI: 10.1038/s41598-021-86284-1] [Reference Citation Analysis]
5 Bessone F. Non-steroidal anti-inflammatory drugs: What is the actual risk of liver damage? World J Gastroenterol 2010; 16(45): 5651-5661 [PMID: 21128314 DOI: 10.3748/wjg.v16.i45.5651] [Cited by in CrossRef: 141] [Cited by in F6Publishing: 114] [Article Influence: 12.8] [Reference Citation Analysis]
6 Aithal GP. Hepatotoxicity related to antirheumatic drugs.Nat Rev Rheumatol. 2011;7:139-150. [PMID: 21263458 DOI: 10.1038/nrrheum.2010.214] [Cited by in Crossref: 102] [Cited by in F6Publishing: 88] [Article Influence: 10.2] [Reference Citation Analysis]
7 Zou W, Devi SS, Sparkenbaugh E, Younis HS, Roth RA, Ganey PE. Hepatotoxic interaction of sulindac with lipopolysaccharide: role of the hemostatic system. Toxicol Sci 2009;108:184-93. [PMID: 19074762 DOI: 10.1093/toxsci/kfn259] [Cited by in Crossref: 46] [Cited by in F6Publishing: 37] [Article Influence: 3.5] [Reference Citation Analysis]
8 Contreras-Zentella ML, Hernández-Muñoz R. Is Liver Enzyme Release Really Associated with Cell Necrosis Induced by Oxidant Stress? Oxid Med Cell Longev 2016;2016:3529149. [PMID: 26798419 DOI: 10.1155/2016/3529149] [Cited by in Crossref: 61] [Cited by in F6Publishing: 47] [Article Influence: 10.2] [Reference Citation Analysis]
9 Lee JK, Paine MF, Brouwer KL. Sulindac and its metabolites inhibit multiple transport proteins in rat and human hepatocytes. J Pharmacol Exp Ther 2010;334:410-8. [PMID: 20430841 DOI: 10.1124/jpet.110.165852] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]